News
QTRX
15.79
+0.25%
0.04
QUANTERIX CORP <QTRX.O>: TD COWEN CUTS TARGET PRICE TO $20 FROM $31
Reuters · 2d ago
Analysts’ Top Healthcare Picks: Quanterix (QTRX), Intuitive Surgical (ISRG)
TipRanks · 3d ago
Weekly Report: what happened at QTRX last week (0408-0412)?
Weekly Report · 3d ago
Quanterix Leadership Changes and Executive Severance Enhancements
TipRanks · 6d ago
QUANTERIX CORP <QTRX.O>: LEERINK PARTNERS CUTS TARGET PRICE TO $30 FROM $35
Reuters · 6d ago
Weekly Report: what happened at QTRX last week (0401-0405)?
Weekly Report · 04/08 12:03
Weekly Report: what happened at QTRX last week (0325-0329)?
Weekly Report · 04/01 11:59
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX)
TipRanks · 03/27 11:00
Quanterix’s Strong IP Position Fuels Buy Rating in Alzheimer’s Diagnostic Market
TipRanks · 03/27 06:56
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
TipRanks · 03/26 11:20
Weekly Report: what happened at QTRX last week (0318-0322)?
Weekly Report · 03/25 12:03
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Oculis Holding (OCS) and Quanterix (QTRX)
Trevi Therapeutics, Oculis Holding and Quanterix have 3 analysts with bullish sentiments on the Healthcare sector. Trevi has a Buy rating from Leerink Partners and is expected to make a move soon. The 3 stocks are most likely to make moves following their insider activities.
TipRanks · 03/25 01:30
TD Cowen Sticks to Their Hold Rating for Quanterix (QTRX)
TipRanks · 03/22 11:25
Quanterix Reveals Specific Partnership Path For Laboratories Interested In Offering Tau Based Research And Diagnostic Testing Services
Benzinga · 03/21 21:32
Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbSci (ABSI)
TipRanks · 03/21 19:10
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
Quanterix Corporation is a leading provider of ultra-sensitive research products and high-definition diagnostics. The company announced a specific partnership path for laboratories interested in offering Tau based research and diagnostic testing services for Alzheimer’s disease. Quanterix has secured over thirty U.S. Patents for its novel approach to measuring Tau protein levels in biologic samples.
Barchart · 03/21 16:30
Weekly Report: what happened at QTRX last week (0311-0315)?
Weekly Report · 03/18 12:01
Weekly Report: what happened at QTRX last week (0304-0308)?
Weekly Report · 03/11 11:56
Quanterix’s Growth Catalysts: FDA Breakthrough Designation and Alzheimer’s Diagnostic Potential
TipRanks · 03/07 04:19
BUZZ-U.S. STOCKS ON THE MOVE-Akero Therapeutics, Vista Outdoor, Sea
Dow Jones Industrial Average down 0.20% on Monday. S&P 500 and Nasdaq's record-closing highs in the prior session. Akero Therapeutics, Vista Outdoor, Sea are among the day's top stocks on thedaq. The U.S. Markets are set to open on a down day.
Reuters · 03/04 19:01
More
Webull provides a variety of real-time QTRX stock news. You can receive the latest news about Quanterix through multiple platforms. This information may help you make smarter investment decisions.
About QTRX
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.